Topiramate: A new Agent for Patients with Alternating Hemiplegia of Childhood

Abstract

Alternating hemiplegia of childhood is a rare syndrome characterized by the onset, before 18 months of age, of frequent attacks of alternating paralysis. Here we report the efficacy of topiramate in four patients with alternating hemiplegia of childhood (AHC) that did not respond to flunarizine, as well as in two newly diagnosed patients. Following treatment with topiramate, the frequency and duration of hemiplegic attacks significantly improved in all patients. Additional symptoms such as seizures, migraine, involuntary movements, autonomic symptoms, and impaired mental development also improved. Topiramate is worth trying when treating patients with AHC as a first trial, or a substitute for flunarizine once the latter agent loses effect.

Key words

Alternating hemiplegia - topiramate - epilepsy - migraine

References

• 1 Verret S, Steele J C. Alternating hemiplegia in childhood: a report of eight patients with complicated migraine beginning in infancy.  Pediatrics. 1971;  47 675-680
• 2 Chi Z F, Guo H Z, Shang W, Li Y Z, Miao J D, Li D N. Alternating hemiplegia of childhood.  Chin J Neurol. 1998;  31 41-43
• 3 Aicardi J. Alternating hemiplegia of childhood.  Int Ped. 1987;  2 115-119
• 4 Casaer P, Azou M. Flunarizine in alternating hemiplegia in childhood.  Lancet. 1984;  2 579
• 5 Casaer P. Flunarizine in alternating hemiplegia in childhood: An international study in 12 children.  Neuropediatrics. 1987;  18 191-195
• 6 Mikati M, Kramer U, Zupanc M. et al . Alternating hemiplegia of childhood: clinical manifestations and long-term outcome.  Pediatric Neurology. 2000;  23 134-141
• 7 Silver K, Andermann F. Alternating hemiplegia of childhood: a study of 10 patients and results of flunarizine treatment.  Neurology. 1993;  43 36-41
• 8 Tada H, Miyake S, Yamada M, Iwamoto H, Morooka K, Sakuragawa N. A patient with alternating hemiplegia in childhood.  No To Hattatsu. 1989;  21 283-288
• 9 Veneselli E, Bianchari R. Alternating hemiplegia of childhood: treatment of attacks with chloral hydrate and niaprazine.  Eur J Pediatr. 1997;  156 157-158
• 10 Korinthenberg R. Is infantile alternating hemiplegia mediated by glutamate toxicity and can it be treated with memantine?.  Neuropediatrics. 1996;  27 277-278
• 11 Sone K, Oguni H, Katsumori H, Funatsuka M, Tanaka T, Osawa M. Successful trial of amantadine hydrochloride for two patients with alternating hemiplegia of childhood.  Neuropediatrics. 2000;  31 307-309
• 12 Kanazawa O, Shirasaka Y, Hattori H, Okuno T, Mikawa H. Ictal 99 mTc-HMPAO SPECT in alternating hemiplegia.  Pediatr Neurol. 1991;  7 121-124
• 13 Saito Y, Sakuragawa N, Sasaki M, Sugai K, Hashimoto T. A case of alternating hemiplegia of childhood with cerebellar atrophy.  Pediatr Neurol. 1998;  19 65-68
• 14 Pfund Z, Chugani D C, Muzik O, Juhasz C, Behen M E, Lee J. et al . Alpha [11C] methyl-L-typtophan positron emission tomography in patients with alternating hemiplegia of childhood.  J Child Neurol. 2002;  17 253-260
• 15 Kors E E, Vanmolkot K R, Haan J, Kheradmand Kia S, Stroink H, Laan L A. et al . Alternating hemiplegia of childhood: no mutations in the second familial hemiplegic migraine gene ATP1A2.  Neuropediatrics. 2004;  35 293-296
• 16 Di Rosa G, Spano M, Pustorino G. et al . Alternating hemiplegia of childhood successfully treated with topiramate: 18 months of follow-up.  Neurology. 2006;  66 146
• 17 Leniger T, Wiemann M, Bingmann D. et al . Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons.  Epilepsia. 2002;  43 469-474
• 18 Ben-Zeev B, Watemberg N, Lerman P. et al . Sulthiame in childhood epilepsy.  Pediatr Int. 2004;  46 521-524
• 19 Tantsura L N, Pilipets Eiu. Use of diacarb in the treatment of children with epilepsy and febrile seizures.  Lik Sprava. 2005;  5 - 6 73-76
• 20 Ophoff R A, Terwindt G M, Uergouwe M N. et al . Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2⁺ channel gene CACNL1A4.  Cell. 1996;  87 543-552